Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

Arthritis Research and Therapy

Volumn 6, Issue 2, 2004, Pages

  Bombardieri, Michele ^a   Alessandri, Cristiano ^a   Labbadia, Giancarlo ^a   Iannuccelli, Cristina ^a   Carlucci, Francesco ^a   Riccieri, Valeria ^a   Paoletti, Vincenzo ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anti cyclic citrullinated peptide antibodies; hepatitis C virus; rheumatoid arthritis; rheumatoid factor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ARTHROPATHY; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MIDDLE AGED; PHYSIOLOGY; RHEUMATOID ARTHRITIS; VIROLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RANGE OF MOTION, ARTICULAR;

EID: 3142743014     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1041     Document Type: Article

References (22)

1. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P: Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group (Multidepartment Virus C). Arthritis Rheum. 1999, 42: 2204-2212. 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D. DOI: 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D
2. Mariette X: The hepatitis C virus and systemic diseases. Rev Rheum. 1998, 65: 737-740.
3. Rivera J, Garcia-Monforte A, Pineda A, Millan Nunez-Cortes J: Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol. 1999, 26: 420-424.
4. Olivieri I, Palazzi C, Padula A: Hepatitis C virus and arthritis. Rheum Dis Clin North Am. 2003, 29: 111-122. 10.1016/S0889-857X(02)00097-2. DOI: 10.1016/S0889-857X(02)00097-2
5. Zuckerman E, Keren D, Rozenbaum M: Hepatitis C virus related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol. 2000, 18: 579-584.
6. Arnett FC, Edworthy SM, Bloch DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. DOI: 10.1002/art.1780310302
7. Vasishta A: Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab. 2002, 21: 34-36.
8. Pinheiro GC, Scheinberg MA, Aparecida da Silva M, Maciel S: Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis. Ann Intern Med. 2003, 139: 234-235. DOI: 10.7326/0003-4819-139-3-200308050-00023
9. van Venrooij WJ, Hazes JM, Visser H: Anticitrullinated protein/ peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002, 60: 383-388.
10. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
11. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-1835. 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6. DOI: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
12. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B: Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis. 2003, 62: 120-126. 10.1136/ard.62.2.120. DOI: 10.1136/ard.62.2.120
13. Bas S, Genevay S, Meyer O, Gabay C: Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology. 2003, 42: 677-680. 10.1093/rheumatology/keg184. DOI: 10.1093/rheumatology/keg184
14. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC: Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC (Groupe d'Étude et de Recherche en Médecine Interne et Maladies Infectieuses sur le Virus de l'Hépatite C). Medicine (Baltimore). 2000, 79: 47-56. 10.1097/00005792-200001000-00005. DOI: 10.1097/00005792-200001000-00005
15. Fadda P, La Civita L, Zignego AL, Ferri C: Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic sindrome. Reumatismo. 2002, 54: 316-323.
16. Lovy MR, Starkebaum G, Uberoi S: Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol. 1996, 23: 979-983.
17. Toubi E, Zuckerman E, Kessel A, Rozenbaum M, Rosner I: IgA rheumatoid factor in patients with chronic HCV infection: prevalence and clinical correlations. Clin Exp Rheumatol. 2003, 21: 524-
18. Kessel A, Rosner I, Zuckerman E, Golan TD, Toubi E: Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. J Rheumatol. 2000, 27: 610-612.
19. van Boekel MAM, Vossenaar ER, van den Hoogen FHJ, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002, 4: 87-93. 10.1186/ar395. DOI: 10.1186/ar395
20. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281. DOI: 10.1172/JCI1316
21. Zuckerman E, Yeshurun D, Rosner I: Management of hepatitis C virus-related arthritis. BioDrugs. 2001, 15: 573-584. DOI: 10.2165/00063030-200115090-00002
22. Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS: Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol. 2000, 18: 363-368.